Iguana Healthcare Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Iguana Healthcare Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$5.55M	Sell	115,000 -10,000	-8%	-$558K	3.65%	4
2017 Q4	$4.92M	Hold	125,000	–	–	3.2%	8
2017 Q3	$3.88M	Sell	125,000 -50,000	-29%	-$1.41M	2.11%	16
2017 Q2	$4.79M	Sell	175,000 -25,000	-13%	-$744K	2.71%	12
2017 Q1	$7.37M	Buy	200,000 +25,000	+14%	+$630K	3.65%	7
2016 Q4	$2.53M	Sell	175,000 -475,000	-73%	-$8.35M	1.51%	26
2016 Q3	$15M	Buy	650,000 +350,000	+117%	+$6.67M	2.67%	13
2016 Q2	$4.98M	Buy	300,000 +50,000	+20%	+$1.01M	2.02%	16
2016 Q1	$3.96M	Buy	250,000 +140,000	+127%	+$2.49M	1.45%	23
2015 Q4	$3.56M	Buy	110,000 +45,000	+69%	+$1.95M	1.17%	24
2015 Q3	$2.74M	Buy	+65,000	New	+$3.07M	1.08%	30

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Iguana Healthcare Management's GBT Position: Q1 2018 in Review

Iguana Healthcare Management reduced its Global Blood Therapeutics, Inc. (GBT) stake by 8% in Q1 2018, selling an estimated $558K and leaving 115,000 shares worth $5.55M. The position accounts for 3.65% of the portfolio, ranked #4.

Iguana Healthcare Management first reported a position in GBT in Q3 2015 and has held it in 11 quarters since. The position peaked at $15M in Q3 2016. 176 funds tracked by Wall St. Rank hold GBT as of Q1 2018.

Iguana Healthcare Management held 115,000 shares of Global Blood Therapeutics, Inc. worth $5.55M as of Q1 2018.
Iguana Healthcare Management sold 10,000 Global Blood Therapeutics, Inc. shares in Q1 2018, an estimated $558K.
Global Blood Therapeutics, Inc. made up 3.65% of Iguana Healthcare Management's portfolio in Q1 2018, its #4 holding.
Iguana Healthcare Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and has held it in 11 quarters since.
Iguana Healthcare Management's Global Blood Therapeutics, Inc. position peaked at $15M in Q3 2016.
176 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.